东方红医疗升级股票发起C(015053)利润分配表
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 收入 |
-100,450,990.68 |
-95,630,396.47 |
8,742,080.44 |
-85,375.03 |
| 利息合计 |
286,404.58 |
149,016.14 |
208,084.18 |
91,084.41 |
| 其中：存款利息收入 |
286,404.58 |
149,016.14 |
208,084.18 |
91,084.41 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-57,890,238.82 |
-41,991,500.30 |
-7,713,802.98 |
-7,141,458.73 |
| 其中：股票投资收益 |
-67,142,629.49 |
-49,166,870.67 |
-13,938,269.95 |
-12,243,771.53 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
137,945.61 |
-44,028.81 |
19,768.51 |
5,412.15 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
9,114,445.06 |
7,219,399.18 |
6,204,698.46 |
5,096,900.65 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-43,595,864.67 |
-54,139,398.55 |
15,214,577.11 |
6,500,746.52 |
| 其他收入 |
748,708.23 |
351,486.24 |
1,033,222.13 |
464,252.77 |
| 费用 |
11,919,873.20 |
5,680,442.56 |
8,482,657.06 |
3,758,496.08 |
| 管理人报酬 |
8,879,493.95 |
4,265,053.10 |
6,503,852.22 |
2,927,975.02 |
| 基金托管费 |
1,479,915.72 |
710,842.20 |
1,083,975.30 |
487,995.78 |
| 销售服务费 |
1,370,667.83 |
612,110.66 |
710,132.37 |
261,754.61 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
189,793.90 |
92,434.80 |
184,697.17 |
80,770.67 |
| 利润总额 |
-112,370,863.88 |
-101,310,839.03 |
259,423.38 |
-3,843,871.11 |
微信公众号
证券之星APP
基本资料
